Lixte Biotechnology

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
EBITDA
-2,540
-2,030
-773
EBIT
-5,104,110
-706
Net Income
-2,543
-2,030
-775
-709
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,087
-926
-487
-568
Cash
5,106
2,887
887
1,384
Basic Shares
48,407
6,171
2,720
2,471

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
EBITDA
-6,000
-3,569
-5,070
-6,303
EBIT
-3,602
-5,086
-6,312
Net Income
-6,009
-3,585
-5,087
-6,312
Net Change In Cash
0
0
0
0
Free Cash Flow
-3,070
-3,164
-4,293
-4,611
Cash
5,106
1,038
4,203
5,353
Basic Shares
48,407
2,249
1,915
158

Earnings Calls

QuarterEPS
2025-12-31
-$0.33
2025-09-30
-$0.33
2025-06-30
-$0.29
2025-03-31
-$0.28